The Biotech Stock Mailbag has a new home. Here’s what readers are saying:
Steve N. writes, “I don’t understand why people are selling Clovis Oncology on this news of a partnership with Bristol-Myers Squibb? Can you explain what I am missing here?”
About the Author Reprints
I subscribed to the Street, now stats
Adam, Great to be able to access your writings again.
Best of luck at STAT. They are lucky to have you.
Keep Writing